Puma Biotechnology, Inc. (PBYI) stock
PBYINasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 14/3019% below fair value
$7.12−0.10 (-1.39%)
Close on Nov 19, 2026Market cap $367.54MP/E 13.7Yield –
Puma Biotechnology total assets
Total assets on the balance sheet at the end of each period.
Puma Biotechnology's total assets was $192.74M at Jun 30, 2026. For fiscal 2025 it was $216.30M, up 1.4% from the year before. Over ten years it grew -1.0% a year on average. The highest annual figure on record is $259.12M in fiscal 2018.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $216.30M | +1.4% |
| FY2024 | Dec 31, 2024 | $213.33M | -7.5% |
| FY2023 | Dec 31, 2023 | $230.53M | +3.8% |
| FY2022 | Dec 31, 2022 | $222.06M | -2.0% |
| FY2021 | Dec 31, 2021 | $226.59M | -7.2% |
| FY2020 | Dec 31, 2020 | $244.22M | +4.0% |
| FY2019 | Dec 31, 2019 | $234.91M | -9.3% |
| FY2018 | Dec 31, 2018 | $259.12M | +56.5% |
| FY2017 | Dec 31, 2017 | $165.53M | -34.5% |
| FY2016 | Dec 31, 2016 | $252.79M | +5.4% |
| FY2015 | Dec 31, 2015 | $239.84M | +47.4% |
| FY2014 | Dec 31, 2014 | $162.76M | +55.9% |
| FY2013 | Dec 31, 2013 | $104.37M | -31.2% |
| FY2012 | Dec 31, 2012 | $151.70M | +173.8% |
| FY2011 | Dec 31, 2011 | $55.40M | +11990809.1% |
| FY2010 | Dec 31, 2010 | $462 | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $192.74M | -1.1% |
| Q1 FY2026 | Mar 31, 2026 | $192.70M | -1.8% |
| Q4 FY2025 | Dec 31, 2025 | $216.30M | +1.4% |
| Q3 FY2025 | Sep 30, 2025 | $202.86M | -8.1% |
| Q2 FY2025 | Jun 30, 2025 | $194.92M | -4.9% |
| Q1 FY2025 | Mar 31, 2025 | $196.18M | -8.4% |
| Q4 FY2024 | Dec 31, 2024 | $213.33M | -7.5% |
| Q3 FY2024 | Sep 30, 2024 | $220.72M | +8.4% |
| Q2 FY2024 | Jun 30, 2024 | $205.00M | +2.2% |
| Q1 FY2024 | Mar 31, 2024 | $214.15M | +9.1% |
| Q4 FY2023 | Dec 31, 2023 | $230.53M | +3.8% |
| Q3 FY2023 | Sep 30, 2023 | $203.61M | +2.4% |
| Q2 FY2023 | Jun 30, 2023 | $200.49M | +3.5% |
| Q1 FY2023 | Mar 31, 2023 | $196.26M | -2.2% |
| Q4 FY2022 | Dec 31, 2022 | $222.06M | -2.0% |
| Q3 FY2022 | Sep 30, 2022 | $198.77M | -12.2% |
| Q2 FY2022 | Jun 30, 2022 | $193.65M | -25.5% |
| Q1 FY2022 | Mar 31, 2022 | $200.69M | -22.4% |
| Q4 FY2021 | Dec 31, 2021 | $226.59M | -7.2% |
| Q3 FY2021 | Sep 30, 2021 | $226.29M | -13.5% |
| Q2 FY2021 | Jun 30, 2021 | $260.00M | -1.4% |
| Q1 FY2021 | Mar 31, 2021 | $258.66M | +14.7% |
| Q4 FY2020 | Dec 31, 2020 | $244.22M | +4.0% |
| Q3 FY2020 | Sep 30, 2020 | $261.70M | +12.8% |
| Q2 FY2020 | Jun 30, 2020 | $263.81M | +10.0% |
| Q1 FY2020 | Mar 31, 2020 | $225.53M | -31.9% |
| Q4 FY2019 | Dec 31, 2019 | $234.91M | -9.3% |
| Q3 FY2019 | Sep 30, 2019 | $232.04M | +0.6% |
| Q2 FY2019 | Jun 30, 2019 | $239.86M | +5.4% |
| Q1 FY2019 | Mar 31, 2019 | $331.36M | +95.3% |
| Q4 FY2018 | Dec 31, 2018 | $259.12M | +56.5% |
| Q3 FY2018 | Sep 30, 2018 | $230.72M | +26.9% |
| Q2 FY2018 | Jun 30, 2018 | $227.62M | +31.7% |
| Q1 FY2018 | Mar 31, 2018 | $169.64M | -21.7% |
| Q4 FY2017 | Dec 31, 2017 | $165.53M | -34.5% |
| Q3 FY2017 | Sep 30, 2017 | $181.86M | +35.7% |
| Q2 FY2017 | Jun 30, 2017 | $172.82M | – |
| Q1 FY2017 | Mar 31, 2017 | $216.62M | – |
| Q4 FY2016 | Dec 31, 2016 | $252.79M | – |
| Q3 FY2016 | Sep 30, 2016 | $134.03M | – |
See a number that looks wrong?